1. Home
  2. INTT vs MSLE Comparison

INTT vs MSLE Comparison

Compare INTT & MSLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo inTest Corporation

INTT

inTest Corporation

HOLD

Current Price

$14.93

Market Cap

175.3M

Sector

Technology

ML Signal

HOLD

MSLE

Satellos Bioscience Inc. Common Stock

N/A

Current Price

$6.13

Market Cap

146.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
INTT
MSLE
Founded
1981
N/A
Country
United States
Canada
Employees
N/A
17
Industry
Semiconductors
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
175.3M
146.9M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
INTT
MSLE
Price
$14.93
$6.13
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$13.50
N/A
AVG Volume (30 Days)
127.2K
120.6K
Earning Date
05-01-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$66,801,000.00
N/A
Revenue This Year
$15.82
N/A
Revenue Next Year
$9.10
N/A
P/E Ratio
N/A
N/A
Revenue Growth
66.06
N/A
52 Week Low
$5.51
$5.50
52 Week High
$15.66
$13.39

Technical Indicators

Market Signals
Indicator
INTT
MSLE
Relative Strength Index (RSI) 59.57 34.94
Support Level $7.21 N/A
Resistance Level $15.34 $7.52
Average True Range (ATR) 0.96 0.70
MACD -0.15 0.01
Stochastic Oscillator 71.72 24.74

Price Performance

Historical Comparison
INTT
MSLE

About INTT inTest Corporation

inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.

About MSLE Satellos Bioscience Inc. Common Stock

Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Share on Social Networks: